Cardinal Health, Inc. – Consensus Indicates Potential -1.5% Downside

DirectorsTalk Interviews

Cardinal Health, Inc. with ticker code (CAH) have now 13 analysts covering the stock. The analyst consensus points to a rating of ‘Hold’. The range between the high target price and low target price is between 80 and 56 and has a mean target at 69.54. With the stocks previous close at 70.63 this would indicate that there is a downside of -1.5%. The day 50 moving average is 62.01 while the 200 day moving average is 56.08. The market cap for the company is $19,046m. Visit the company website at: https://www.cardinalhealth.com

The potential market cap would be $18,752m based on the market concensus.

Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Share on:

Latest Company News

Corero lands new Tier-1 wins as Edison sees growth accelerating – Edison

Edison says two fresh customer wins at Corero Network Security support its case that partner-led sales and newer products are broadening the.

Strix cash surge and Consumer Goods momentum put the spotlight on the next strategic update – Zeus Capital

Zeus Capital says Strix’s FY26 results were broadly in line, but the standout was a sharp improvement in cash, a stronger Consumer.

Hercules launches dedicated Power & Energy Services division to target UK infrastructure investment

Hercules has created a standalone Power & Energy Services division and appointed Marcus White to lead growth across UK electricity infrastructure programmes.

Likewise latest research note from Zeus Capital highlights progress and growth potential

Zeus Capital’s latest research note on Likewise points to continued operational progress, with the broker maintaining a positive view on the group’s prospects in the UK flooring market.

Nativo Resources Plc latest research note highlights progress and near-term catalysts from the broker

A latest research note on Nativo Resources Plc highlights progress across the company’s portfolio, with attention on operational delivery, project optionality and the potential for further value creation as work advances.

Norcros latest research note from Zeus Capital highlights resilient trading and strategic progress

Zeus Capital’s latest research note on Norcros points to a business that continues to trade resiliently, with management maintaining focus on margin, cash generation and strategic delivery across its portfolio.

    Search